{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-25-029225","form_type":"8-K","ticker":"AVTX","cik":"0001534120","company_name":"Avalo Therapeutics, Inc.","filed_at":"2025-06-04T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.663049+00:00","generated_at":"2026-05-19T23:52:25.002584+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"low","headline":"Avalo Therapeutics posts updated investor presentation; content not disclosed in filing","bullets":["Company posted updated investor presentation on its website on June 4, 2025.","No specific financial or operational updates from the presentation were included in the filing.","Investors are directed to the company's website for full content."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-25-029225","json":"https://secwatch.observer/filing/0001628280-25-029225.json","markdown":"https://secwatch.observer/filing/0001628280-25-029225.md","text":"https://secwatch.observer/filing/0001628280-25-029225.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1534120/000162828025029225/0001628280-25-029225-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1534120/000162828025029225/avtx-20250604.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T23:52:25.002584+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}